Melatonin Warning: EU Market Entry for Supplement Brands

Melatonin Warning: What Supplement Brands Need to Know for EU Market Entry. This video is crucial for any supplement brand looking to sell melatonin products in the European Union, especially Germany. We'll uncover why melatonin is no longer a simple sleep aid and how higher doses can classify your product as a medicinal drug. Learn about the specific regulatory affairs challenges, how to classify your product correctly, and the importance of compliant labeling and marketing. Discover key German retail channels and proactive steps to ensure your dietary supplements meet EU standards. Nutri.Markets analyzes 25+ countries - regulations, retailers, competitors, and market opportunities in minutes: https://nutri.markets. This content is for educational purposes only and not legal advice.

Chapters:
00:00 Hook
00:16 Melatonin: Not a Gentle Sleep Aid
00:28 Higher Doses = Medicinal Product?
00:39 What Changed
00:53 What Changed
01:07 Vulnerable Groups Need Caution
01:19 No Fixed Max Dose, But Risks
01:31 EU Brands Selling Melatonin
01:43 Sleep Claims Must Be Narrow
01:56 Classify Your Product Correctly
02:06 Verify Dose and Formulation
02:17 Compliant Labeling is Crucial
02:26 Notify the BVL Before Market
02:37 Document Traceability and Quality
02:47 Review Marketing for Compliance
02:56 Action Steps
03:07 Key German Retail Channels
03:19 No New Deadlines, Act Proactively
03:31 Cta